Kantarjian H - Search Results

1

Safety and tolerability of AMG 330 in adults with relapsed/refractory AML: a phase 1a dose-escalation study.

Ravandi F, Subklewe M, Walter RB, Vachhani P, Ossenkoppele G, Buecklein V, Döhner H, Jongen-Lavrencic M, Baldus CD, Fransecky L, Pardee TS, Kantarjian H, Yen PK, Mukundan L, Panwar B, Yago MR, Agarwal S, Khaldoyanidi SK, Stein A. Ravandi F, et al. Among authors: kantarjian h. Leuk Lymphoma. 2024 Sep;65(9):1281-1291. doi: 10.1080/10428194.2024.2346755. Epub 2024 May 7. Leuk Lymphoma. 2024. PMID: 38712673 Clinical Trial.

2

Cytogenetics for detection of minimal residual disease in acute myeloblastic leukemia.

Freireich EJ, Cork A, Stass SA, McCredie KB, Keating MJ, Estey EH, Kantarjian HM, Trujillo JM. Freireich EJ, et al. Among authors: kantarjian hm. Leukemia. 1992 Jun;6(6):500-6. Leukemia. 1992. PMID: 1602788

3

Investigation of karyotypic, morphologic and clinical features in patients with acute myeloid leukemia blast cells expressing the neural cell adhesion molecule (CD56).

Seymour JF, Pierce SA, Kantarjian HM, Keating MJ, Estey EH. Seymour JF, et al. Among authors: kantarjian hm. Leukemia. 1994 May;8(5):823-6. Leukemia. 1994. PMID: 7514247

4

High-dose cytosine arabinoside in chronic lymphocytic leukemia: a clinical and pharmacologic analysis.

Robertson LE, Hall R, Keating MJ, Estey E, Kantarjian HM, McLaughlin P, Hagemeister FB, Plunkett W. Robertson LE, et al. Among authors: kantarjian hm. Leuk Lymphoma. 1993 May;10(1-2):43-8. doi: 10.3109/10428199309147355. Leuk Lymphoma. 1993. PMID: 8374522

5

Causes of initial remission induction failure in patients with acute myeloid leukemia and myelodysplastic syndromes.

Anderlini P, Luna M, Kantarjian HM, O'Brien S, Pierce S, Keating MJ, Estey EH. Anderlini P, et al. Among authors: kantarjian hm. Leukemia. 1996 Apr;10(4):600-8. Leukemia. 1996. PMID: 8618434 Clinical Trial.

6

Evaluation of CI-973, a platinum analogue, in refractory or relapsed acute leukemia.

Kantarjian HM, Beran M, O'Brien S, Robertson L, Siddik Z, Yoshida M, Yang LY, Rios MB, Keating MJ, Meyer M, et al. Kantarjian HM, et al. Leukemia. 1996 Mar;10(3):396-401. Leukemia. 1996. PMID: 8642853 Clinical Trial.

7

Acute lymphoblastic leukemia following preleukemic syndromes in adults.

Escudier SM, Albitar M, Robertson LE, Andreeff M, Pierce S, Kantarjian HM. Escudier SM, et al. Among authors: kantarjian hm. Leukemia. 1996 Mar;10(3):473-7. Leukemia. 1996. PMID: 8642864

8

Amsacrine and continuous-infusion high-dose cytosine arabinoside as induction therapy for patients with newly-diagnosed acute myelogenous leukemia.

Ghaddar HM, Pierce S, Kantarjian HM, Freireich EJ, Keating MJ, Estey EH. Ghaddar HM, et al. Among authors: kantarjian hm. Leuk Lymphoma. 1996 Jun;22(1-2):71-6. doi: 10.3109/10428199609051730. Leuk Lymphoma. 1996. PMID: 8724530 Clinical Trial.

9

Thrombosis in patients with acute promyelocytic leukemia treated with and without all-trans retinoic acid.

Escudier SM, Kantarjian HM, Estey EH. Escudier SM, et al. Among authors: kantarjian hm. Leuk Lymphoma. 1996 Feb;20(5-6):435-9. doi: 10.3109/10428199609052425. Leuk Lymphoma. 1996. PMID: 8833399 Clinical Trial.

10

Clinical and laboratory studies of 2-chlorodeoxyadenosine +/- cytosine arabinoside for relapsed or refractory acute myelogenous leukemia in adults.

Kornblau SM, Gandhi V, Andreeff HM, Beran M, Kantarjian HM, Koller CA, O'Brien S, Plunkett W, Estey E. Kornblau SM, et al. Among authors: kantarjian hm. Leukemia. 1996 Oct;10(10):1563-9. Leukemia. 1996. PMID: 8847890 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,546 results

Search Page

Filters